Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC.

Nat Cell Biol. 2011 Mar;13(3):317-23. doi: 10.1038/ncb2173. Epub 2011 Feb 20. Erratum in: Nat Cell Biol. 2011 Dec;13(12):1466. Nat Cell Biol. 2011 Dec;13(12):1467.

2.

Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.

Ren D, Wang M, Guo W, Zhao X, Tu X, Huang S, Zou X, Peng X.

Int J Oncol. 2013 Apr;42(4):1473-81. doi: 10.3892/ijo.2013.1825. Epub 2013 Feb 12.

PMID:
23404342
3.

p53 Spreads out further: suppression of EMT and stemness by activating miR-200c expression.

Schubert J, Brabletz T.

Cell Res. 2011 May;21(5):705-7. doi: 10.1038/cr.2011.62. Epub 2011 Apr 12. No abstract available.

4.

Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.

Ye J, Wei X, Shang Y, Pan Q, Yang M, Tian Y, He Y, Peng Z, Chen L, Chen W, Wang R.

Oncogene. 2017 Nov 16;36(46):6391-6407. doi: 10.1038/onc.2017.241. Epub 2017 Jul 24.

PMID:
28745318
5.

Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).

Pan Q, Meng L, Ye J, Wei X, Shang Y, Tian Y, He Y, Peng Z, Chen L, Chen W, Bian X, Wang R.

Cancer Lett. 2017 Apr 28;392:26-38. doi: 10.1016/j.canlet.2017.01.039. Epub 2017 Feb 2.

PMID:
28163188
6.

MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.

Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN, Lee HJ, Park SY.

Breast Cancer Res Treat. 2014 Aug;147(1):39-49. doi: 10.1007/s10549-014-3069-5. Epub 2014 Aug 3.

PMID:
25086633
7.

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.

Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, White BA.

Breast Cancer Res Treat. 2012 Feb;132(1):75-85. doi: 10.1007/s10549-011-1534-y. Epub 2011 May 7.

PMID:
21553120
8.

Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.

Knezevic J, Pfefferle AD, Petrovic I, Greene SB, Perou CM, Rosen JM.

Oncogene. 2015 Dec 3;34(49):5997-6006. doi: 10.1038/onc.2015.48. Epub 2015 Mar 9.

9.

MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.

Ma C, Ding YC, Yu W, Wang Q, Meng B, Huang T.

Minerva Med. 2015 Aug;106(4):193-202. Epub 2015 Jun 17.

PMID:
26081037
10.

miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.

Mutlu M, Raza U, Saatci Ö, Eyüpoğlu E, Yurdusev E, Şahin Ö.

J Mol Med (Berl). 2016 Jun;94(6):629-44. doi: 10.1007/s00109-016-1420-5. Epub 2016 Apr 20. Review.

PMID:
27094812
11.

Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.

Zhang W, Qian P, Zhang X, Zhang M, Wang H, Wu M, Kong X, Tan S, Ding K, Perry JK, Wu Z, Cao Y, Lobie PE, Zhu T.

J Biol Chem. 2015 May 29;290(22):13812-29. doi: 10.1074/jbc.M115.653261. Epub 2015 Apr 14.

12.

Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.

Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, Qin LX, Yamashita T, Woo HG, Kim YJ, Kaneko S, Tang ZY, Thorgeirsson SS, Wang XW.

Hepatology. 2012 Nov;56(5):1792-803. doi: 10.1002/hep.25890. Epub 2012 Aug 22.

13.

Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.

Feng ZM, Qiu J, Chen XW, Liao RX, Liao XY, Zhang LP, Chen X, Li Y, Chen ZT, Sun JG.

BMC Cancer. 2015 Sep 23;15:645. doi: 10.1186/s12885-015-1655-5.

14.

MicroRNA-200c-141 and ∆Np63 are required for breast epithelial differentiation and branching morphogenesis.

Hilmarsdóttir B, Briem E, Sigurdsson V, Franzdóttir SR, Ringnér M, Arason AJ, Bergthorsson JT, Magnusson MK, Gudjonsson T.

Dev Biol. 2015 Jul 15;403(2):150-61. doi: 10.1016/j.ydbio.2015.05.007. Epub 2015 May 9.

15.

Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.

Fomeshi MR, Ebrahimi M, Mowla SJ, Khosravani P, Firouzi J, Khayatzadeh H.

Cell Mol Biol Lett. 2015 Sep;20(3):448-65. doi: 10.1515/cmble-2015-0025.

PMID:
26208390
16.

Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.

Karimi Dermani F, Saidijam M, Amini R, Mahdavinezhad A, Heydari K, Najafi R.

J Cell Biochem. 2017 Jun;118(6):1547-1555. doi: 10.1002/jcb.25816. Epub 2016 Dec 13.

PMID:
27918105
17.

MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.

Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY, Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT.

Hepatology. 2015 Sep;62(3):801-15. doi: 10.1002/hep.27887. Epub 2015 Jul 3.

PMID:
25953743
18.

Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.

Si L, Jiang F, Li Y, Ye X, Mu J, Wang X, Ning S, Hu C, Li Z.

Mol Carcinog. 2015 Sep;54(9):859-69. doi: 10.1002/mc.22157. Epub 2014 Apr 14.

PMID:
24729530
19.

Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.

Ren D, Wang M, Guo W, Huang S, Wang Z, Zhao X, Du H, Song L, Peng X.

Cell Tissue Res. 2014 Dec;358(3):763-78. doi: 10.1007/s00441-014-2001-y. Epub 2014 Oct 9.

PMID:
25296715
20.

MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.

Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N, Zhu Z, Mo Z, Wu C, Chen X.

Cancer Sci. 2012 Jun;103(6):1058-64. doi: 10.1111/j.1349-7006.2012.02281.x. Epub 2012 Apr 23.

Supplemental Content

Support Center